230 related articles for article (PubMed ID: 31016513)
21. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
[TBL] [Abstract][Full Text] [Related]
22. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
[TBL] [Abstract][Full Text] [Related]
23. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
24. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.
Afable MG; Wlodarski M; Makishima H; Shaik M; Sekeres MA; Tiu RV; Kalaycio M; O'Keefe CL; Maciejewski JP
Blood; 2011 Jun; 117(25):6876-84. PubMed ID: 21527527
[TBL] [Abstract][Full Text] [Related]
25. Somatic Mutations in Aplastic Anemia.
Mufti GJ; Marsh JCW
Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
[TBL] [Abstract][Full Text] [Related]
26. Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
Bräuninger A; Blau W; Kunze K; Desch AK; Brobeil A; Tur MK; Etschmann B; Günther U; Körholz D; Schliesser G; Käbisch A; Kiehl M; Rummel M; Gattenlöhner S
J Mol Diagn; 2018 May; 20(3):344-354. PubMed ID: 29471115
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.
Kulasekararaj AG; Jiang J; Smith AE; Mohamedali AM; Mian S; Gandhi S; Gaken J; Czepulkowski B; Marsh JC; Mufti GJ
Blood; 2014 Oct; 124(17):2698-704. PubMed ID: 25139356
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.
Liu L; Zhang D; Fu Q; Wang J; Yu J; Chen D; Wang F; Guo R; Xie X; Jiang Z; Li Y
Clin Exp Med; 2023 Dec; 23(8):4473-4482. PubMed ID: 37087521
[TBL] [Abstract][Full Text] [Related]
29. Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation.
Durrani J; Groarke EM
Semin Hematol; 2022 Jul; 59(3):137-142. PubMed ID: 36115690
[TBL] [Abstract][Full Text] [Related]
30. Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes.
Giudice V; Banaszak LG; Gutierrez-Rodrigues F; Kajigaya S; Panjwani R; Ibanez MDPF; Rios O; Bleck CK; Stempinski ES; Raffo DQ; Townsley DM; Young NS
Haematologica; 2018 Jul; 103(7):1150-1159. PubMed ID: 29674506
[TBL] [Abstract][Full Text] [Related]
31. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Duncavage EJ; Tandon B
Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
[TBL] [Abstract][Full Text] [Related]
32. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
[TBL] [Abstract][Full Text] [Related]
33. Clonality in context: hematopoietic clones in their marrow environment.
Cooper JN; Young NS
Blood; 2017 Nov; 130(22):2363-2372. PubMed ID: 29046282
[TBL] [Abstract][Full Text] [Related]
34. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).
Li X; Xu F; He Q; Wu L; Zhang Z; Chang C
Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647
[TBL] [Abstract][Full Text] [Related]
35. [Clonal hematopoiesis in aplastic anemia].
Makishima H
Rinsho Ketsueki; 2018; 59(10):1962-1968. PubMed ID: 30305498
[TBL] [Abstract][Full Text] [Related]
36. Aplastic anemia evolving into overt myelodysplastic syndrome/acute myeloid leukemia with t(3;5)(p25;q31).
Kawata E; Kuroda J; Kimura S; Kamitsuji Y; Kobayashi Y; Yoshikawa T
Cancer Genet Cytogenet; 2002 Sep; 137(2):91-4. PubMed ID: 12393278
[TBL] [Abstract][Full Text] [Related]
37. Utility of plasma cell-free DNA for
Gutierrez-Rodrigues F; Beerman I; Groarke EM; Patel BA; Spitofsky N; Dillon LW; Raffo DQ; Hourigan CS; Kajigaya S; Ferrucci L; Young NS
Haematologica; 2022 Aug; 107(8):1815-1826. PubMed ID: 34587721
[TBL] [Abstract][Full Text] [Related]
38. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Field JJ; Mason PJ; An P; Kasai Y; McLellan M; Jaeger S; Barnes YJ; King AA; Bessler M; Wilson DB
J Pediatr Hematol Oncol; 2006 Jul; 28(7):450-3. PubMed ID: 16825992
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathogenesis of acquired aplastic anemia.
Boddu PC; Kadia TM
Eur J Haematol; 2019 Feb; 102(2):103-110. PubMed ID: 30380171
[TBL] [Abstract][Full Text] [Related]
40. Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes.
Sutton JF; Stacey M; Kearns WG; Rieg TS; Young NS; Liu JM
Pediatr Blood Cancer; 2004 Feb; 42(2):122-6. PubMed ID: 14752874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
